Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
20.08. | CLEARBRIDGE HEALTH LIMITED: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF SUBSTANTIAL SHAREHOLDER(S)/UNITHOLDER(S)::DISCLOSURE OF CHANGE IN INTEREST OF SUBSTANTIAL SHAREHOLDERS-YEE PINH JEREMY | 2 | SGX Company Announcements | ||
20.08. | CLEARBRIDGE HEALTH LIMITED: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF SUBSTANTIAL SHAREHOLDER(S)/UNITHOLDER(S)::DISCLOSURE OF CHANGE IN INTEREST OF SUBSTANTIAL SHAREHOLDERS-COOP INTERNATIONAL & BONVESTS HOLDINGS | 3 | SGX Company Announcements | ||
CLEARBRIDGE HEALTH Aktie jetzt für 0€ handeln | |||||
20.08. | CLEARBRIDGE HEALTH LIMITED: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF SUBSTANTIAL SHAREHOLDER(S)/UNITHOLDER(S)::DISCLOSURE OF CHANGE IN INTEREST OF SUBSTANTIAL SHAREHOLDERS-CHEN JOHNSON | 3 | SGX Company Announcements | ||
19.08. | Clearbridge Health raises $1.98m from 990 million placement shares | 2 | Singapore Business Review | ||
18.08. | CLEARBRIDGE HEALTH LIMITED: GENERAL ANNOUNCEMENT::CBH RAISED S$1.98 MILLION FROM PLACEMENT; BACKED BY HIGH-PROFILE INVESTORS TO FUEL STRATEGIC GROWTH | 2 | SGX Company Announcements | ||
18.08. | CLEARBRIDGE HEALTH LIMITED: PLACEMENTS::COMPLETION OF THE PROPOSED PLACEMENT CUM WARRANT ISSUE | 2 | SGX Company Announcements | ||
13.08. | CLEARBRIDGE HEALTH LIMITED: PLACEMENTS::RECEIPT OF LISTING AND QUOTATION NOTICE | - | SGX Company Announcements | ||
04.08. | CLEARBRIDGE HEALTH LIMITED: PLACEMENTS::THE PROPOSED PLACEMENT OF UP TO 990,000,000 PLACEMENT SHARES & 660,000,000 WARRANTS IN THE COMPANY | 1 | SGX Company Announcements | ||
31.07. | CLEARBRIDGE HEALTH LIMITED: ASSET ACQUISITIONS AND DISPOSALS::ANNOUNCEMENT PURSUANT TO RULE 706A OF THE LISTING MANUAL | 1 | SGX Company Announcements | ||
31.07. | CLEARBRIDGE HEALTH LIMITED: FINANCIAL STATEMENTS AND RELATED ANNOUNCEMENT::HALF YEARLY RESULTS | 1 | SGX Company Announcements | ||
18.07. | CLEARBRIDGE HEALTH LIMITED: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF SUBSTANTIAL SHAREHOLDER(S)/UNITHOLDER(S)::CESSATION OF SUBSTANTIAL SHAREHOLDER - WONG KONG LEONG | 3 | SGX Company Announcements | ||
20.06. | CLEARBRIDGE HEALTH LIMITED: GENERAL ANNOUNCEMENT::USE OF PROCEEDS FROM THE RIGHTS ISSUE | 2 | SGX Company Announcements | ||
19.06. | CLEARBRIDGE HEALTH LIMITED: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF SUBSTANTIAL SHAREHOLDER(S)/UNITHOLDER(S)::DISCLOSURE OF CHANGE IN INTEREST OF SUBSTANTIAL SHAREHOLDERS - WONG KONG LEONG | - | SGX Company Announcements | ||
16.06. | CLEARBRIDGE HEALTH LIMITED: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF SUBSTANTIAL SHAREHOLDER(S)/UNITHOLDER(S)::BECOMING A SUBSTANTIAL SHAREHOLDER - WONG KONG LEONG | 1 | SGX Company Announcements | ||
16.06. | CLEARBRIDGE HEALTH LIMITED: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF SUBSTANTIAL SHAREHOLDER(S)/UNITHOLDER(S)::CESSATION OF SUBSTANTIAL SHAREHOLDER - ONG CHOON YI | 1 | SGX Company Announcements | ||
12.06. | CLEARBRIDGE HEALTH LIMITED: CHANGE - CHANGE OF CATALIST SPONSOR::CHANGE OF CONTINUING SPONSOR | - | SGX Company Announcements | ||
06.06. | CLEARBRIDGE HEALTH LIMITED: GENERAL ANNOUNCEMENT::ENTRY INTO STRATEGIC ALLIANCE AGREEMENT | - | SGX Company Announcements | ||
29.05. | CLEARBRIDGE HEALTH LIMITED: GENERAL ANNOUNCEMENT::MINUTES OF THE ANNUAL GENERAL MEETING HELD ON 30 APRIL 2025 | - | SGX Company Announcements | ||
06.05. | CLEARBRIDGE HEALTH LIMITED: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF DIRECTOR/CHIEF EXECUTIVE OFFICER::DISCLOSURE OF CHANGE IN DIRECTOR'S INTEREST - CHEN JOHNSON | 1 | SGX Company Announcements | ||
06.05. | CLEARBRIDGE HEALTH LIMITED: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF DIRECTOR/CHIEF EXECUTIVE OFFICER::DISCLOSURE OF CHANGE IN DIRECTOR'S INTEREST - YEE PINH JEREMY | 2 | SGX Company Announcements |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
ALIGNMENT HEALTHCARE | 16,320 | +1,81 % | Alignment Healthcare, Inc. - 8-K, Current Report | ||
KINDLY MD | 1,240 | 0,00 % | KindlyMD, Inc: KindlyMD Approved for Options Trading on Nasdaq | SALT LAKE CITY, UT / ACCESS Newswire / September 10, 2025 / KindlyMD, Inc. (NASDAQ:NAKA) ("KindlyMD" or "the Company"), a provider of integrated healthcare services and a Bitcoin treasury vehicle via... ► Artikel lesen | |
NANOVIBRONIX | 10,700 | 0,00 % | NanoVibronix files to sell 1.35M shares of common stock for holders | ||
BRIGHTSPRING HEALTH SERVICES | 27,180 | +2,76 % | BrightSpring Health: UBS bestätigt Kaufempfehlung angesichts starker Wachstumsaussichten | ||
BETA BIONICS | 25,310 | -4,17 % | Beta Bionics, Inc.: Beta Bionics Reports Second Quarter 2025 Financial Results and Raises Full Year 2025 Guidance | IRVINE, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
FRESENIUS | 47,130 | +0,58 % | +40 Prozent seit Jahresbeginn: Fresenius kehrt mit Milliarden-Anleihe zurück - Analysten empfehlen zum Kauf! | © Foto: Arne Dedert/dpaFresenius stärkt mit einer Milliarden-Anleihe seine Bilanz und Analysten sehen trotz Rallye weiteres Kurspotenzial für die Aktie.Der Gesundheitskonzern Fresenius ist mit einer... ► Artikel lesen | |
OPTIMIZERX | 17,330 | 0,00 % | OptimizeRx Corporation: OptimizeRx Partners with Lamar Advertising to Reach Clinically Relevant Audiences Through Out-of-Home Healthcare Advertising | Strategic Partnership Combines OptimizeRx's Patented Micro-Neighborhood® Targeting Data with Lamar's Vast Nationwide OOH Network to Strengthen OOH Media for Healthcare Marketing WALTHAM, Mass., Sept.... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 42,430 | +0,88 % | Fresenius Medical Care: Weniger Patienten, schrumpfende Margen - Analysten raten zum Verkauf | Die UBS bleibt bei ihrer Verkaufsempfehlung für Fresenius Medical Care (FMC) und warnt vor tiefgreifenden Risiken für das Geschäftsmodell. Fortschritte bei der Behandlung von Diabetes und Bluthochdruck... ► Artikel lesen | |
PRIVIA HEALTH GROUP | 22,340 | -1,93 % | Privia Health Group, Inc.: Privia Health Reports Second Quarter 2025 Financial Results | Very Strong First Half Performance Across All Key Operating and Financial MetricsImplemented Providers +13.8% and Practice Collections +18.5% compared to 2Q'24Guidance Raised to Above High End of... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 47,790 | -0,04 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
PROCEPT BIOROBOTICS | 37,980 | 0,00 % | PROCEPT BioRobotics Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance | SAN JOSE, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
OMADA HEALTH | 22,140 | 0,00 % | Omada Health Announces Pricing of Initial Public Offering | SAN FRANCISCO--(BUSINESS WIRE)--Omada Health, the virtual between-visit healthcare provider, today announced the pricing of its initial public offering of 7,900,000 shares of its common stock, at a... ► Artikel lesen | |
NUTEX HEALTH | 95,66 | 0,00 % | Nutex Health, Inc.: Nutex Health Provides Financial Reporting Update | HOUSTON, Aug. 20, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system... ► Artikel lesen | |
UNITEDHEALTH | 295,65 | -0,05 % | Neues Futter für Bullen: UnitedHealth überrascht mit Gewinnprognose für 2025 - Aktie steigt! | © Foto: SOPA Images - Sipa USAUnitedHealth bekräftigt trotz steigender Kosten seinen Jahresausblick, die Aktie reagiert mit einem Kurssprung von 1,5 Prozent.Die Aktie von UnitedHealth Group legte am... ► Artikel lesen | |
MIMEDX | 6,970 | +0,43 % | MiMedx Group, Inc: MIMEDX Announces Record Second Quarter 2025 Operating and Financial Results | Highest Quarterly Net Sales in MIMEDX History Second Quarter Net Sales of $99 million Grew 13% Year-Over-Year Second Quarter GAAP Net Income and Diluted Earnings Per Share were $10 Million and $0.06... ► Artikel lesen |